Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials

BACKGROUND: We sought to develop a prognostic scoring system to aid in patient selection for immune checkpoint inhibitor (ICI) phase 1 clinical trials. METHODS: Clinical data from patients treated in phase 1 ICI clinical trials at MD Anderson (MDA) Center were analysed. Seventeen clinical factors we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Shiraj, Hess, Kenneth, Hong, David S, Naing, Aung, Piha-Paul, Sarina, Janku, Filip, Fu, Siqing, Subbiah, Ishwaria M, Liu, Holly, Khanji, Rahil, Huang, Le, Moorthy, Shhyam, Karp, Daniel D, Tsimberidou, Apostolia, Meric-Bernstam, Funda, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886120/
https://www.ncbi.nlm.nih.gov/pubmed/29462132
http://dx.doi.org/10.1038/bjc.2017.480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886120/
https://www.ncbi.nlm.nih.gov/pubmed/29462132
http://dx.doi.org/10.1038/bjc.2017.480

Ejemplares similares